Microwave ablation without subsequent lumpectomy versus breast-conserving surgery for early breast cancer: a propensity score matching study

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA A Cancer J Clinicians. 2022;72(1):7–33.
   PubMed Web of Science ®Google Scholar
• Soerjomataram I, Louwman MWJ, Ribot JG, et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008;107(3):309–330.
   PubMed Web of Science ®Google Scholar
• García-Tejedor A, Guma A, Soler T, et al. Radiofrequency ablation followed by surgical excision versus lumpectomy for early stage breast cancer: a randomized phase II clinical trial. Radiology. 2018;289(2):317–324.
   PubMed Web of Science ®Google Scholar
• Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–1232.
   PubMed Web of Science ®Google Scholar
• Lagendijk M, van Maaren MC, Saadatmand S, et al. Breast conserving therapy and mastectomy revisited: breast cancer-specific survival and the influence of prognostic factors in 129,692 patients: BCT and mastectomy revisited. Int J Cancer. 2018;142(1):165–175.
   PubMed Web of Science ®Google Scholar
• Litière S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20-year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–419.
   PubMed Web of Science ®Google Scholar
• Goh BKP, Yong W-S. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2004;100(8):1766–1766.
   PubMed Web of Science ®Google Scholar
• Thiessen FEF, Tjalma WAA, Tondu T. Breast reconstruction after breast conservation therapy for breast cancer. Eur J Obstet Gynecol Reprod Biol. 2018;230:233–238.
   PubMed Web of Science ®Google Scholar
• Waljee JF, Hu ES, Newman LA, et al. Predictors of breast asymmetry after breast-conserving operation for breast cancer. J Am Coll Surg. 2008;206(2):274–280.
   PubMed Web of Science ®Google Scholar
• Fleming MM, Holbrook AI, Newell MS. Update on image-guided percutaneous ablation of breast cancer. AJR Am J Roentgenol. 2017;208(2):267–274.
   PubMed Web of Science ®Google Scholar
• Peek MCL, Ahmed M, Napoli A, et al. Minimally invasive ablative techniques in the treatment of breast cancer: a systematic review and meta-analysis. Int J Hyperthermia. 2017;33(2):191–202.
   PubMed Web of Science ®Google Scholar
• Zhou W, Jiang Y, Chen L, et al. Image and pathological changes after microwave ablation of breast cancer: a pilot study. Eur J Radiol. 2014;83(10):1771–1777.
   PubMed Web of Science ®Google Scholar
• Yu J, Han Z, Li T, et al. Microwave ablation versus nipple sparing mastectomy for breast cancer ≤5 cm: a pilot cohort study. Front Oncol. 2020;10:546883.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zha X, Liu X, et al. US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. Radiology. 2012;263(2):364–373.
   PubMed Web of Science ®Google Scholar
• Telli ML, Gradishar WJ, Ward JH. NCCN guidelines updates: Breast cancer. J Natl Compr Canc Netw. 2019;17:552–555.
   PubMed Web of Science ®Google Scholar
• Nanda A, Hu J, Hodgkinson S, et al. Oncoplastic breast-conserving surgery for women with primary breast cancer. Cochrane Database Syst Rev. 2021;10(10):CD013658.
   PubMed Web of Science ®Google Scholar
• Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J Vasc Interv Radiol. 2017;28(10):1432–1437.e3.
   PubMed Web of Science ®Google Scholar
• Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002;52(5):277–300.
   PubMed Web of Science ®Google Scholar
• Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17–24.
   PubMed Web of Science ®Google Scholar
• Minami CA, King TA, Mittendorf EA. Patient preferences for locoregional therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020;183(2):291–309.
   PubMed Web of Science ®Google Scholar
• Palussière J, Henriques C, Mauriac L, et al. Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes. Radiology. 2012;264(2):597–605.
   PubMed Web of Science ®Google Scholar
• Nori J, Gill MK, Meattini I, et al. The evolving role of ultrasound guided percutaneous laser ablation in elderly unresectable breast cancer patients: a feasibility pilot study. BioMed Res Int. 2018;2018:1–7.
   Web of Science ®Google Scholar
• Susini T, Nori J, Olivieri S, et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol. 2007;104(2):304–310.
   PubMed Web of Science ®Google Scholar
• Mauri G, Sconfienza LM, Pescatori LC, et al. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: a systematic review and meta-analysis. Eur Radiol. 2017;27(8):3199–3210.
   PubMed Web of Science ®Google Scholar
• Field TS, Bosco JLF, Prout MN, et al. Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer. J Am Coll Surg. 2011;213(6):757–765.
   PubMed Web of Science ®Google Scholar
• Nault J-C, Sutter O, Nahon P, et al. Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations. J Hepatol. 2018;68(4):783–797.
   PubMed Web of Science ®Google Scholar
• Xu X-F, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–217.
   PubMed Web of Science ®Google Scholar
• Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385–1393.
   PubMed Web of Science ®Google Scholar
• Strandberg R, Czene K, Eriksson M, et al. Estimating distributions of breast cancer onset and growth in a swedish mammography screening cohort. Cancer Epidemiol Biomarkers Prev. 2022;31(3):569–577.
   PubMed Web of Science ®Google Scholar
• Bailey SL, Sigal BM, Plevritis SK. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40–49 years. J Natl Cancer Inst. 2010;102(16):1263–1271.
   PubMedGoogle Scholar
• Li C, Yao M, Shao S, et al. Diagnostic efficacy of contrast-enhanced ultrasound for breast lesions of different sizes: a comparative study with magnetic resonance imaging. Br J Radiol. 2020;93(1110):20190932.
   PubMed Web of Science ®Google Scholar